Integrin cell adhesion receptors and the concept of agonism

Trends in Pharmacological Sciences

Volumn 21, Issue 1, 2000, Pages 29-32

  Humphries, Martin J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN; INTEGRIN RECEPTOR; RECEPTOR BLOCKING AGENT; SELECTIN;

AGONIST; ALLOSTERISM; CELL ADHESION; CELL GROWTH; CELL MOTILITY; CELL SHAPE; DRUG BINDING SITE; DRUG RECEPTOR BINDING; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW;

ANIMALS; CELL ADHESION; HUMANS; INTEGRINS; RECEPTORS, CYTOADHESIN; SIGNAL TRANSDUCTION;

EID: 0033982205     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01410-8     Document Type: Review

References (42)

1. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
2. Lutz K.L.et al. Structure, function and modulation of E-cadherins as mediators of cell-cell adhesion. Curr. Top. Pept. Protein Res. 2:1997;69-82.
3. Vestweber D., Blanks J.E. Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 79:1999;181-213.
4. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
5. Juliano R.L., Haskill S. Signal transduction from the extracellular matrix. J. Cell Biol. 120:1993;577-585.
6. Yamada K.M., Miyamoto S. Integrin transmembrane signaling and cytoskeletal control. Curr. Opin. Cell Biol. 7:1995;681-689.
7. Schoenwaelder S.M., Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr. Opin. Cell Biol. 11:1999;274-286.
8. Dedhar S. Integrins and signal transduction. Curr. Opin. Hematol. 6:1999;37-43.
9. Sheetz M.P.et al. Cell migration: regulation of force on extracellular-matrix-integrin complexes. Trends Cell Biol. 8:1998;51-54.
10. Humphries M.J. Cell-substrate adhesion assays. Current Protocols Cell Biol. 1998;9.1.1-9.1.11.
11. Hughes P., Pfaff M. Trends Cell Biol. 8:1998;359-364.
12. Huhtala P.et al. Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol. 129:1995;867-879.
13. Humphries M.J. The molecular basis and specificity of integrin-ligand interactions. J. Cell Sci. 97:1990;585-592.
14. Jones E.Y.et al. Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution. Nature. 373:1995;539-544.
15. Leahy D.J.et al. 2.0 Å crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell. 84:1996;155-164.
16. Obara M.et al. Site-directed mutagenesis of the cell-binding domain of human fibronectin: separable, synergistic sites mediate adhesive function. Cell. 53:1988;649-657.
17. Newham P.et al. α4 Integrin binding interfaces on VCAM-1 and MAdCAM-1. Integrin binding footprints identify accessory binding sites that play a role in integrin specificity. J. Biol. Chem. 272:1997;19429-19440.
18. Tuckwell D.S.et al. A secondary structure model of the integrin α subunit N-terminal domain based on analysis of multiple alignments. Cell Adhes. Commun. 2:1994;385-402.
19. Springer T.A. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain. Proc. Natl. Acad. Sci. U. S. A. 94:1997;65-72.
20. Lee J.O.et al. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18). Cell. 80:1995;631-638.
21. Tuckwell D.S., Humphries M.J. A structure prediction for the ligand-binding region of the integrin β subunit: evidence for the presence of a von Willebrand factor A domain. FEBS Lett. 400:1997;297-303.
22. Tozer E.C.et al. Ligand binding to integrin αIIbβ3 is dependent on a MIDAS-like domain in the β3 subunit. J. Biol. Chem. 271:1996;21978-21984.
23. Humphries M.J., Newham P. The structure of cell-adhesion molecules. Trends Cell Biol. 8:1998;78-83.
24. Takada Y., Puzon W. Identification of a regulatory region of integrin β1 subunit using activating and inhibiting antibodies. J. Biol. Chem. 268:1993;17597-17601.
25. Irie A.et al. Critical amino acid residues for ligand binding are clustered in a predicted β-turn of the third N-terminal repeat in the integrin α4 and α5 subunits. EMBO J. 14:1995;5550-5556.
26. D'Souza S.E.et al. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science. 242:1988;91-93.
27. Smith J.W., Cheresh D.A. The Arg-Gly-Asp binding domain of the vitronectin receptor. Photoaffinity cross-linking implicates amino acid residues 61-203 of the β subunit. J. Biol. Chem. 263:1988;18726-18731.
28. Humphries M.J. Integrin activation: the link between ligand binding and signal transduction. Curr. Opin. Cell Biol. 8:1996;632-640.
29. Mould A.P. Getting integrins into shape: recent insights into how integrin activity is regulated by conformational changes. J. Cell Sci. 109:1996;2613-2618.
30. Lee J.O.et al. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure. 3:1995;1333-1340.
31. Loftus J.C., Liddington R.C. New insights into integrin-ligand interaction. J. Clin. Invest. 99:1997;2302-2306.
32. Mould A.P.et al. Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin α5β1. Biochem. J. 331:1998;821-828.
33. Mould A.P.et al. The inhibitory anti-β1 integrin monoclonal antibody 13 recognizes an epitope that is attenuated by ligand occupancy. Evidence for allosteric inhibition of integrin function. J. Biol. Chem. 271:1996;20365-20374.
34. Newham P.et al. Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin α4β1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes. J. Immunol. 160:1998;4508-4517.
35. Mould A.P.et al. Defining the topology of integrin α5β1-fibronectin interactions using inhibitory anti-α5 and anti-β1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the α5 subunit. J. Biol. Chem. 272:1997;17283-17292.
36. Burrows L.et al. Fine mapping of inhibitory anti-α5 monoclonal antibody epitopes that differentially affect integrin-ligand binding. Biochem J. 1999;. (in press).
37. Oxvig C., Springer T.A. Experimental support for a β-propeller domain in integrin α-subunits and a calcium binding site on its lower surface. Proc. Natl. Acad. Sci. U. S. A. 95:1998;870-4875.
38. Humphries M.et al. Integrin antagonists as modulators of adhesion. Expert Opin. Ther. Pat. 4:1994;227-235.
39. Coller B.S. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J. Clin. Invest. 99:1997;1467-1471.
40. Elices M.J. Blockade of the VLA-4 integrin as a therapy for airway inflammation in respiratory disease. Curr. Opin. Anti-Inflammatory Immunomodulatory Invest. Drugs. 1:1999;14-20.
41. Subbarao V.et al. Update on glycoprotein IIb/IIIa inhibitors. Curr. Opin. Cardiovasc. 1:1999;56-62.
42. Eliceiri B.P., Cheresh D.A. The role of αV integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103:1999;1227-1230.